Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Zolty

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Expert Review of Cardiovascular Therapy|May 21, 2019
Challenges in pulmonary hypertension associated with left heart diseaseRonald Zolty
Journal of Cardiac Failure|January 28, 2017
Pulmonary Hypertension in Left Ventricular Dysfunction: Still Numerous Unanswered QuestionsRonald Zolty
Expert Opinion on Drug Discovery|April 4, 2023
Advances in the discovery of drugs that treat pulmonary arterial hypertensionRonald Zolty
Journal of Experimental Pharmacology|August 25, 2021
Novel Experimental Therapies for Treatment of Pulmonary Arterial HypertensionRonald Zolty
Pharmacology & Therapeutics|May 18, 2020
Pulmonary arterial hypertension specific therapy: The old and the newRonald Zolty
Expert Opinion on Pharmacotherapy|December 6, 2025
Antiproliferative therapies in pulmonary arterial hypertensionRonald Zolty
Heart Failure Reviews|February 27, 2014
Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screeningLuise Holzhauser, Ronald Zolty
Journal of Cardiac Failure|August 6, 2013
Association of hyponatremia and outcomes in pulmonary hypertensionAsaf Rabinovitz, Farbod Raiszadeh, Ronald Zolty
Clinical Cardiology|February 27, 2010
A left hemiblock improves cardiac resynchronization therapy outcomes in patients with a right bundle branch blockRamesh Chandra, Ronald Zolty, Eugen Palma
Journal of Cardiac Failure|December 5, 2012
Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysisSupriya Shore, Vikas Aggarwal, Ronald Zolty
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Expert Review of Cardiovascular Therapy|May 21, 2019
Challenges in pulmonary hypertension associated with left heart diseaseRonald Zolty
Journal of Cardiac Failure|January 28, 2017
Pulmonary Hypertension in Left Ventricular Dysfunction: Still Numerous Unanswered QuestionsRonald Zolty
Expert Opinion on Drug Discovery|April 4, 2023
Advances in the discovery of drugs that treat pulmonary arterial hypertensionRonald Zolty
Journal of Experimental Pharmacology|August 25, 2021
Novel Experimental Therapies for Treatment of Pulmonary Arterial HypertensionRonald Zolty
Pharmacology & Therapeutics|May 18, 2020
Pulmonary arterial hypertension specific therapy: The old and the newRonald Zolty
Expert Opinion on Pharmacotherapy|December 6, 2025
Antiproliferative therapies in pulmonary arterial hypertensionRonald Zolty
Heart Failure Reviews|February 27, 2014
Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screeningLuise Holzhauser, Ronald Zolty
Journal of Cardiac Failure|August 6, 2013
Association of hyponatremia and outcomes in pulmonary hypertensionAsaf Rabinovitz, Farbod Raiszadeh, Ronald Zolty
Clinical Cardiology|February 27, 2010
A left hemiblock improves cardiac resynchronization therapy outcomes in patients with a right bundle branch blockRamesh Chandra, Ronald Zolty, Eugen Palma
Journal of Cardiac Failure|December 5, 2012
Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysisSupriya Shore, Vikas Aggarwal, Ronald Zolty
Pageof 8